We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Hampton caught

25 September 2014 By Neil Unmack, Chris Hughes

Philip Hampton is to join drug giant GSK in January, but may not succeed Chris Gent as chairman until next September. The long transition reflects the difficulty of replacing Hampton at state-backed RBS in an election year. For GSK, the ambiguity in board leadership is unhelpful.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)